ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

VIRX Viracta Therapeutics Inc

0.8102
-0.0298 (-3.55%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Viracta Therapeutics Inc VIRX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.0298 -3.55% 0.8102 13:00:07
始値 安値 高値 終値 前日終値
0.8212 0.80 0.84 0.8102 0.84
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1521:00GLOBEViracta Therapeutics Announces Positive Topline Nana-val..
2024/4/0121:30GLOBEViracta Therapeutics to Present Topline Nana-val Results..
2024/3/0807:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0806:19EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0806:12EDGAR2Form 8-K - Current report
2024/3/0806:05GLOBEViracta Therapeutics Reports Fourth Quarter and Full Year..
2024/2/2922:00GLOBEViracta Therapeutics Announces Completion of Second-Stage..
2024/2/2810:40EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2809:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2809:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1411:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/0706:05GLOBEViracta Therapeutics to Present at the Oppenheimer 34th..
2024/1/0422:00GLOBEViracta Therapeutics Provides Clinical Update and Outlook..
2023/12/1222:00GLOBEViracta Therapeutics Announces Orphan Drug Designation..
2023/12/0506:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0422:30GLOBEViracta Therapeutics Announces Interim Data from Phase 1b/2..
2023/11/2909:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2909:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1807:30EDGAR2Form 8-K - Current report
2023/11/1006:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0922:30EDGAR2Form 8-K - Current report
2023/11/0922:30GLOBEViracta Therapeutics Reports Third Quarter 2023 Financial..
2023/11/0806:15GLOBEViracta Therapeutics to Present at Upcoming Investor..
2023/10/0420:01EDGAR2Form 8-K - Current report
2023/10/0420:00GLOBEViracta Therapeutics to Host R&D Day Highlighting Nana-val..
2023/9/0522:00GLOBEViracta Therapeutics to Host R&D Day on October 4, 2023
2023/8/3007:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/3007:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1905:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1905:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1905:05GLOBEViracta Therapeutics Announces New Employment Inducement..
2023/8/1706:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/8/1505:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1421:02EDGAR2Form 8-K - Current report
2023/8/1421:00GLOBEViracta Therapeutics Reports Second Quarter 2023 Financial..
2023/8/0821:30GLOBEViracta Therapeutics Announces Publication in Blood Advances..
2023/8/0720:36EDGAR2Form 8-K - Current report
2023/8/0720:30GLOBEViracta Therapeutics Appoints Darrel P. Cohen, M.D., Ph.D...
2023/6/2821:00GLOBEViracta Therapeutics’ Pivotal NAVAL-1 Trial Achieves..
2023/6/0105:15GLOBEViracta Therapeutics to Present at the Jefferies Healthcare..
2023/5/1205:05GLOBEViracta Therapeutics to Present at the RBC Capital Markets..
2023/5/0905:05GLOBEViracta Therapeutics Reports First Quarter 2023 Financial..

最近閲覧した銘柄

Delayed Upgrade Clock